News from Perrigo Company A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

May 03, 2016, 08:53 ET Perrigo And Allergan Announce First-To-Market Launch Of Store Brand OTC Equivalent To Mucinex® 1200mg DM Extended-Release Tablets

 Perrigo Company (NYSE: PRGO; TASE) and its partner Allergan plc (NYSE: AGN) today announced the launch of guaifenesin 1200mg and...


Mar 23, 2016, 08:30 ET Perrigo And Allergan Announce First-To-Market Launch Of Store Brand OTC Equivalent To Mucinex® 1200mg ER Tablets

Perrigo Company (NYSE: PRGO; TASE) and its partner Allergan plc (NYSE: AGN)  today announced the launch of guaifenesin 1200mg extended-release...


Jul 30, 2014, 08:10 ET Perrigo Confirms First To File Patent Challenge For Generic Version Of Topicort® Topical Spray 0.25%

Perrigo Company (NYSE: PRGO;TASE) announced that it has filed with the U.S. Food and Drug Administration (FDA) an Abbreviated New Drug Application...


Jul 24, 2014, 12:55 ET Perrigo Confirms AB Therapeutic Equivalent Rating From The FDA For Its Testosterone Gel 1.0%

 Perrigo Company (NYSE: PRGO; TASE) today announced that it has received an AB therapeutic equivalent rating from the U.S. Food and Drug...


Jul 08, 2014, 08:47 ET Perrigo Announces FDA Final Approval For The Store Brand Equivalent To Advil® Congestion Relief Tablets, 200 mg/10 mg

Perrigo Company (NYSE: PRGO; TASE) today announced that it was the first to receive final approval from the U.S. Food and Drug Administration for...


Mar 12, 2014, 08:43 ET Perrigo Announces Launch Of Generic Version Of Neptazane™ (Methazolamide) Tablets

Perrigo Company (NYSE: PRGO; TASE) today announced that it has launched, through a distribution and supply agreement, methazolamide tablets, the...


Jan 14, 2014, 14:57 ET Perrigo Announces FDA Final Approval for Generic Version of Vanos® (Fluocinonide) Cream 0.1%

 Perrigo Company (NYSE: PRGO; TASE) today announced that it has received final approval for its abbreviated new drug application ("ANDA") for...


Dec 13, 2013, 07:56 ET Perrigo Company And Elan Corporation plc Receive Irish High Court Approval For Perrigo's Proposed Acquisition Of Elan

 Perrigo Company (NYSE: PRGO; TASE) and Elan Corporation, plc (NYSE: ELN) ("Elan") today announced that the Irish High Court has approved...


Nov 21, 2013, 08:00 ET Perrigo Company Announces Receipt of Requisite Consents for and Pricing of Its Previously Announced Tender Offer and Consent Solicitation for its 2.950% Notes due 2023

 Perrigo Company (NYSE, TASE: PRGO) today announced that, in connection with its offer to purchase for cash (the "Tender Offer") any and all...


Nov 20, 2013, 11:22 ET Perrigo Confirms Filing For Generic Version Of Acanya

 Perrigo Company (NYSE: PRGO;TASE) announced that it has filed with the U.S. Food and Drug Administration (FDA) an Abbreviated New Drug...


Nov 06, 2013, 09:37 ET Perrigo Company Announces Quarterly Dividend

 Perrigo Company (NYSE: PRGO;TASE) today announced that its Board of Directors declared a quarterly dividend of $0.09 per share, payable on...


Nov 05, 2013, 09:14 ET Perrigo Company Announces Tender Offer and Consent Solicitation for its 2.950% Notes due 2023

 Perrigo Company (NYSE, TASE: PRGO) today announced that it is commencing a tender offer to purchase any and all of its outstanding $600...


Nov 01, 2013, 15:16 ET Perrigo Initiates Nationwide Voluntary Product Recall Of Acetaminophen Infant Suspension Liquid, 160 mg/5 mL, Due To A Potential Defect With The Co-Packaged Oral Syringe

 The Perrigo Company (NYSE: PRGO; TASE) announced today that it has initiated a voluntary, nationwide product recall to the retail level of...


Oct 31, 2013, 07:41 ET Perrigo Reports Record First Quarter Revenue, Adjusted Earnings And Margins

 Perrigo Company (NYSE: PRGO; TASE) today announced results for its first quarter ended September 28, 2013. Perrigo's Chairman and CEO...


Oct 24, 2013, 09:14 ET Perrigo Company To Release First Quarter Fiscal Year 2014 Results On October 31, 2013

Perrigo Company (NYSE: PRGO;TASE:) today announced that it will release financial results for its first quarter fiscal year 2014  on...


Oct 09, 2013, 18:01 ET Perrigo Company Announces Date Of Special Shareholder Meeting In Connection With Acquisition Of Elan Corporation, plc

 Perrigo Company (NYSE, TASE: PRGO) today announced that it has scheduled a shareholder meeting for Monday, November 18, 2013 in connection...


Sep 23, 2013, 09:00 ET Perrigo Announces FDA Final Approval For Generic Version Of Nitrolingual® Spray, 400 mcg/spray

 Perrigo Company (NYSE: PRGO; TASE) today announced that it has received final approval for its abbreviated new drug application for...


Sep 20, 2013, 09:50 ET Perrigo Company Appoints FDA Veteran As New Head Of Regulatory Review

 Perrigo Company (NYSE: PRGO; TASE) today announced the appointment of Keith Webber as Head of...


Sep 10, 2013, 09:29 ET Perrigo Company Announces FDA Final Approval For The Store Brand Equivalent To Children's Zyrtec® Allergy Syrup, 1 mg/mL

 Perrigo Company (NYSE: PRGO; TASE) today announced that it has received final approval from the U.S. Food and Drug Administration for its...


Sep 10, 2013, 09:22 ET Perrigo Company To Present At Upcoming Healthcare Conferences

 Perrigo Company (NYSE: PRGO; TASE) today announced that Perrigo Chairman, President and CEO Joseph C. Papa will present at the Morgan Stanley...


Aug 28, 2013, 12:36 ET Perrigo Files Registration Statement On Form S-4 In Connection With Proposed Acquisition Of Elan

 Perrigo Company (NYSE, TASE: PRGO) ("Perrigo") and Elan Corporation, plc. (NYSE: ELN) ("Elan") today announced that Perrigo Company Limited...


Aug 14, 2013, 08:30 ET Perrigo Company Announces Quarterly Dividend

 Perrigo Company (NYSE: PRGO;TASE) today announced that its Board of Directors declared a quarterly dividend of $0.09 per share, payable on...


Aug 12, 2013, 08:58 ET Teva Pharmaceuticals And Perrigo Company Announce The U.S. Launch Of Generic Temozolomide

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) and Perrigo Company (NYSE: PRGO;TASE) today announced the launch of the generic equivalent to...


Aug 02, 2013, 09:00 ET Perrigo Company Will Release Fourth Quarter And Fiscal Year 2013 Results On August 15, 2013

 Perrigo Company (NYSE: PRGO, "Perrigo") today announced that it it will release financial results for its fourth quarter and fiscal year 2013...


Jul 31, 2013, 09:00 ET Perrigo Announces FDA Final Approval For Generic Equivalent To Cutivate® Lotion, 0.05%

 Perrigo Company (NYSE: PRGO; TASE) today announced that it has received final approval for its abbreviated new drug application for...